Details for Patent: 7,619,004

Which drugs does patent 7,619,004 protect, and when does it expire?

Patent 7,619,004 protects COLCRYS and is included in one NDA.

Summary for Patent: 7,619,004

Patent landscape, scope, and claims:

Title:	Methods for concomitant administration of colchicine and macrolide antibiotics
Abstract:	Methods for concomitant administration of colchicine together with one or more macrolide antibiotics, e.g., clarithromycin or erythromycin, are disclosed. Such methods reduce the dangers commonly associated with such concomitant administration and provide additional benefits. Methods of notifying health care practitioners and patients regarding appropriate dosing for co-administration of colchicine together with macrolide antibiotics are also provided.
Inventor(s):	Davis; Matthew W. (Erwinna, PA)
Assignee:	Mutual Pharmaceutical Company, Inc. (Philadelphia, PA)
Application Number:	12/327,258
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,619,004
Patent Claim Types: see list of patent claims	Use; Dosage form;

Drugs Protected by US Patent 7,619,004

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Takeda Pharms Usa	COLCRYS	colchicine	TABLET;ORAL	022352-001	Jul 29, 2009		DISCN	Yes	No						METHOD OF USING COLCHICINE FOR THE PROPHYLAXIS OF GOUT FLARES